Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radioiodine Dose in Thyroid Ablation
NCT00115895Phase 3Unknown
- Sponsor
- University of Helsinki
- Start
- Jan 2000
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of iodine-131 in thyroid cancer (2 arms), sponsored by University of Helsinki. Primary endpoint: Cumulative number of radioactive iodine administrations at 15 years. Status: unknown.
02
Drugs
iodine-131
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT00115895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115895.